IgY for Inhibition of Pathological Modified Peptides in Celiac Disease
</a><strong>Background</strong><br>
Celiac disease is a worldwide autoimmune disorder characterized by gluten intolerance, and is associated with a number of serious clinical conditions. Even though the prevalence of celiac disease is about 1%, there is still no special therapy; therefore people with celiac disease have to follow a strict gluten-free diet.<br><br> <strong>Technology</strong><br> We offer a novel polyclonal IgY antibody for the treatment of Celiac Disease. The treatment is based on the application of polyclonal anti-CD3 or anti-CDPtTG antibodies, which recognize a specific pathogen peptide. The antibodies are able to bind CD3-peptides and to inhibit human autoantibodies against tTG, without activating the immune system. <br><br> The antibodies are produced in high quantities in the egg yolk of chicken through specific immunization. <br><br> <b>Benefits:</b><ul> <li>Polyclonal chicken antibodies expressed in yolk (no purification necessary)</li> <li>Inhibition of all tested patient autoantibodies against CDP and tTG (75 pts.)</li> <li>Inhibition of tTG enzymatic activity</li> <li>No interaction with non-pathogenic unmodified gluten </li></ul> <p><strong>IP Rights</strong><br> German patent application filed 09/2011 <br><br> <strong>Patent Owner</strong><br> Charité – Universitätsmedizin Berlin
Further Information: PDF
ipal GmbH
Phone: +49 (0)30/2125-4820
Contact
Dr. Dirk Dantz
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Superradiant atoms could push the boundaries of how precisely time can be measured
Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…
Ion thermoelectric conversion devices for near room temperature
The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…
Zap Energy achieves 37-million-degree temperatures in a compact device
New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…